Anbio Biotechnology (NASDAQ:NNNN) Shares Down 18.5% – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) shares were down 18.5% on Monday . The stock traded as low as $18.28 and last traded at $18.7480. Approximately 12,022 shares traded hands during mid-day trading, a decline of 72% from the average daily volume of 43,236 shares. The stock had previously closed at $22.99.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Anbio Biotechnology Trading Down 21.1%

The firm has a 50 day moving average of $27.93.

Anbio Biotechnology (NASDAQ:NNNN) last posted its quarterly earnings data on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.